You can buy or sell BLFS and other stocks, options, ETFs, and crypto commission-free!
BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. Read More The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.
52 Week High
52 Week Low
Advertising and Marketing
Seeking AlphaMay 9
Biolife Solutions' CEO Mike Rice on Q1 2019 Results - Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Mike Rice – President and Chief Executive Officer Roderick de Greef – Chief Financial Officer Conference Call Participants Suraj Kalia – Northland Securities Paul Knight – Janney Montgomery William March – Spring City Partners Operator Good day, ladies and gentlemen and welcome to the BioLife Solutions, Inc. First Quarter Earnings Conference Call. At this time, all participants are in ...
PR NewswireMay 9
BioLife Solutions Announces First Quarter 2019 Financial Results
BOTHELL, Wash., May 9, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), the leading developer, manufacturer and marketer of proprietary biopreservation media and automated cell thawing media devices for cell and gene therapies, today reported financial results and operational highlights for the three months ended March 31, 2019. Revenue from biopreservation media product sales for the first quarter of 2019 reached a record $5.8 million, an increase of 51% compared w...
$0.03 per share
$0.02 per share